Bayer Agrees With Decision to Pull Part of Roundup Settlement
July 08 2020 - 12:02PM
Dow Jones News
By Micah Maidenberg
Bayer AG said it agrees with a move from attorneys representing
plaintiffs who sued over the safety of its Roundup weedkiller to
withdraw a motion seeking court approval for a plan covering how
future claims related to the product would be resolved.
That motion is part of a $10.9 billion settlement the German
pharmaceutical and agriculture conglomerate reached in June to
settle tens of thousands of lawsuits with U.S. plaintiffs who have
alleged the Roundup herbicide causes cancer.
A spokesman for Bayer confirmed the company agreed with
attorneys for the plaintiffs to pull back on the motion. Bayer has
said it would set aside $1.25 billion to work toward resolving
future claims, which would be guided by conclusions from a
court-approved panel of scientists who studied Roundup's potential
carcinogenicity.
On Monday, U.S. District Judge Vince Chhabria in San Francisco
said he was skeptical of Bayer's plan to capture all future claims
tied to Roundup, and would likely reject it.
"Bayer remains strongly committed to a resolution that
simultaneously addresses both the current litigation on reasonable
terms and a viable solution to manage and resolve potential future
litigation," the company said in a statement on Wednesday.
Write to Micah Maidenberg at micah.maidenberg@wsj.com
(END) Dow Jones Newswires
July 08, 2020 11:47 ET (15:47 GMT)
Copyright (c) 2020 Dow Jones & Company, Inc.
Bayer (TG:BAYN)
Historical Stock Chart
From Feb 2024 to Mar 2024
Bayer (TG:BAYN)
Historical Stock Chart
From Mar 2023 to Mar 2024